from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1110/lytB2

LFCtreatmentdescriptionclass of inhibitor

-0.863

Amikacinug/mL Amikacintranslation

0.125

Cap5-10ug/mL Capreomycintranslation

-0.752

Rox10-50 ug/mL Roxithromycintranslation

-0.170

SM2-5 ug/mL Streptomycintranslation

-0.866

Tet5-10 ug/mL Tetracyclinetranslation

-0.326

Rif0.2-5ug/mL Rifampicintranscription

-0.892

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.159

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.909

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.150

CPZ10-50 ug/mL Chlorpromazinerespiration

0.713

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.215

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.777

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.338

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.319

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.219

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.490

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.446

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.906

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.555

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.753

KCN5-20 ug/mL Potassium cyaniderespiration

0.067

NaN30.2-2 mM Sodium aziderespiration

-0.593

Nigericin50 uM Nigericinrespiration

-0.600

TRC10-150 ug/mL Triclosanrespiration

0.894

TRZ10-25 ug/mL Thioridazinerespiration

0.275

Valinomycin0.5-10 uM Valinomycinrespiration

-0.479

ZnSO42 mM ZnSO4respiration

0.932

menadione6-10 ug/mL Menadionerespiration

0.589

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.526

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.016

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.582

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.853

NRP_1Non-replicating persistence stage 1dosRassociated

-0.326

Amp0.2mg/mL AmpicillincellWall

-0.199

Cephalexin20-100 ug/mL CephalexincellWall

-0.274

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.314

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.152

EMB10-20 ug/mL EthambutolcellWall

0.209

Eta12-40 ug/mL EthionamidecellWall

0.199

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.282

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.859

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.162

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.492

BZA0.12 mg/mL BenzamidearomaticAmides

-0.836

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.732

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.420

H2O24 mM hydrogen peroxideDNAdamaging

-0.189

Levo10 ug/mL LevofloxacinDNAdamaging

-0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.595

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.187

UVUV-irradiationDNAdamaging

1.505

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.270

Antimycin12.5-50 ug/mL Antimycin A?

-0.579

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.129

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.485

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.057

PA8240.2-2 ug/mL PA-824?

1.275

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.397

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.357

Verapamil50 uM Verapamil?

-0.484

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.516

methoxatin10-20 ug/mL Methoxatin?